Puretech Health Plc Stock Buy Hold or Sell Recommendation
| PRTC Stock | USD 16.82 0.11 0.66% |
Given the investment horizon of 90 days and your highly speculative risk level, our recommendation regarding PureTech Health PLC is 'Strong Sell'. Macroaxis provides PureTech Health buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding PRTC positions.
Check out PureTech Health Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as PureTech and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards PureTech Health PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
PureTech |
Execute PureTech Health Buy or Sell Advice
The PureTech recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on PureTech Health PLC. Macroaxis does not own or have any residual interests in PureTech Health PLC or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute PureTech Health's advice using the current market data and latest reported fundamentals.
Time Horizon
30 Days |
Risk Tolerance
I love taking a lot of risk |
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
PureTech Health Trading Alerts and Improvement Suggestions
| PureTech Health PLC generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 3.33 M. Net Loss for the year was (65.7 M) with loss before overhead, payroll, taxes, and interest of (81.55 M). | |
| PureTech Health PLC currently holds about 368.03 M in cash with (105.92 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 12.84. | |
| PureTech Health PLC has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: PureTech Health stock hits 52-week low at 16.71 amid market challenges - Investing.com UK |
PureTech Health current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. PureTech analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. PureTech analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Average Consensus Strong Buy
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
PureTech Health Returns Distribution Density
The distribution of PureTech Health's historical returns is an attempt to chart the uncertainty of PureTech Health's future price movements. The chart of the probability distribution of PureTech Health daily returns describes the distribution of returns around its average expected value. We use PureTech Health PLC price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of PureTech Health returns is essential to provide solid investment advice for PureTech Health.
| Mean Return | -0.36 |
| Value At Risk | -5.77 |
| Potential Upside | 3.04 |
| Standard Deviation | 2.59 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of PureTech Health historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
PureTech Stock Institutional Investors
| Shares | |||
| Birch Hill Investment Advisors Llc | 2024-12-31 | 302 K | |
| Millennium Management Llc | 2024-12-31 | 45.3 K | |
| Pentwater Capital Management Lp | 2024-12-31 | 24.1 K | |
| Ubs Group Ag | 2024-12-31 | 1.9 K | |
| Morgan Stanley - Brokerage Accounts | 2024-12-31 | 100.0 | |
| Adar1 Capital Management Llc | 2024-12-31 | 0.0 | |
| Tower Research Capital Llc | 2024-09-30 | 0.0 |
PureTech Health Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | 271.5M | 61.8M | (315.8M) | 41.2M | 37.1M | 38.9M | |
| Free Cash Flow | (137.3M) | (163.9M) | (181.0M) | (106.2M) | (95.5M) | (100.3M) | |
| Depreciation | 6.6M | 7.3M | 8.9M | 4.9M | 5.7M | 3.9M | |
| Other Non Cash Items | 6.1M | (5.1M) | (111.1M) | (67.1M) | (60.4M) | (57.4M) | |
| Dividends Paid | 1.1M | 112K | 367K | 393K | 452.0K | 311.7K | |
| Capital Expenditures | 5.4M | 5.7M | 2.2M | 245K | 281.8K | 267.7K | |
| Net Income | 4.6M | (62.7M) | (37.1M) | (65.7M) | (75.6M) | (71.8M) | |
| End Period Cash Flow | 403.9M | 465.7M | 149.9M | 191.1M | 219.7M | 165.9M | |
| Investments | 369.6M | 217.6M | (107.2M) | 69.0M | 79.3M | 89.8M | |
| Net Borrowings | 6.0M | (250K) | 36.9M | (1.2M) | (1.3M) | (1.3M) | |
| Change To Netincome | (41.9M) | (541.0M) | (135.9M) | (105.9M) | (95.3M) | (100.0M) |
PureTech Health Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to PureTech Health or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that PureTech Health's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a PureTech stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.37 | |
β | Beta against Dow Jones | -0.15 | |
σ | Overall volatility | 2.64 | |
Ir | Information ratio | -0.14 |
PureTech Health Volatility Alert
PureTech Health PLC exhibits very low volatility with skewness of -0.15 and kurtosis of 0.79. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure PureTech Health's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact PureTech Health's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.PureTech Health Fundamentals Vs Peers
Comparing PureTech Health's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze PureTech Health's direct or indirect competition across all of the common fundamentals between PureTech Health and the related equities. This way, we can detect undervalued stocks with similar characteristics as PureTech Health or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of PureTech Health's fundamental indicators could also be used in its relative valuation, which is a method of valuing PureTech Health by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare PureTech Health to competition |
| Fundamentals | PureTech Health | Peer Average |
| Return On Equity | -0.22 | -0.31 |
| Return On Asset | -0.13 | -0.14 |
| Operating Margin | (230.55) % | (5.51) % |
| Current Valuation | (71.39 M) | 16.62 B |
| Shares Outstanding | 24.02 M | 571.82 M |
| Shares Owned By Institutions | 1.56 % | 39.21 % |
| Number Of Shares Shorted | 23.42 K | 4.71 M |
| Price To Book | 1.28 X | 9.51 X |
| Price To Sales | 868.90 X | 11.42 X |
| Revenue | 3.33 M | 9.43 B |
| Gross Profit | (81.55 M) | 27.38 B |
| EBITDA | (11.63 M) | 3.9 B |
| Net Income | (65.7 M) | 570.98 M |
| Cash And Equivalents | 368.03 M | 2.7 B |
| Cash Per Share | 12.84 X | 5.01 X |
| Total Debt | 25.34 M | 5.32 B |
| Debt To Equity | 0.08 % | 48.70 % |
| Current Ratio | 2.54 X | 2.16 X |
| Book Value Per Share | 1.32 X | 1.93 K |
| Cash Flow From Operations | (105.92 M) | 971.22 M |
| Short Ratio | 16.97 X | 4.00 X |
| Earnings Per Share | (3.00) X | 3.12 X |
| Target Price | 53.25 | |
| Number Of Employees | 90 | 18.84 K |
| Beta | 0.98 | -0.15 |
| Market Capitalization | 406.64 M | 19.03 B |
| Total Asset | 693.97 M | 29.47 B |
| Retained Earnings | 83.82 M | 9.33 B |
| Working Capital | 295.83 M | 1.48 B |
| Net Asset | 693.97 M |
PureTech Health Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as PureTech . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 16.82 | |||
| Day Typical Price | 16.82 | |||
| Price Action Indicator | 0.055 | |||
| Period Momentum Indicator | 0.11 | |||
| Relative Strength Index | 46.04 |
About PureTech Health Buy or Sell Advice
When is the right time to buy or sell PureTech Health PLC? Buying financial instruments such as PureTech Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having PureTech Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Emerging Markets Funds Thematic Idea Now
Emerging Markets Funds
Fund or Etfs that invest in markets of developing countries. The Emerging Markets Funds theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Emerging Markets Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out PureTech Health Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PureTech Health. If investors know PureTech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PureTech Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.615 | Earnings Share (3.00) | Revenue Per Share | Quarterly Revenue Growth (0.91) | Return On Assets |
The market value of PureTech Health PLC is measured differently than its book value, which is the value of PureTech that is recorded on the company's balance sheet. Investors also form their own opinion of PureTech Health's value that differs from its market value or its book value, called intrinsic value, which is PureTech Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PureTech Health's market value can be influenced by many factors that don't directly affect PureTech Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PureTech Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if PureTech Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PureTech Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.